Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
3.381
+0.031 (0.92%)
Nov 21, 2024, 11:29 AM EST - Market open
Clover Health Investments Revenue
Clover Health Investments had revenue of $330.99M in the quarter ending September 30, 2024, with 8.29% growth. This brings the company's revenue in the last twelve months to $2.12B, up 13.50% year-over-year. In the year 2023, Clover Health Investments had annual revenue of $2.04B, down -43.11%.
Revenue (ttm)
$2.12B
Revenue Growth
+13.50%
P/S Ratio
0.77
Revenue / Employee
$3,831,920
Employees
552
Market Cap
1.68B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GoodRx Holdings | 790.39M |
10x Genomics | 629.74M |
Certara | 372.80M |
Immunocore Holdings | 296.31M |
Dynavax Technologies | 260.81M |
Xencor | 85.16M |
Nurix Therapeutics | 56.42M |
Celldex Therapeutics | 9.98M |
CLOV News
- 2 days ago - Clover Health: Buy The Dip, Reap The Rewards - Seeking Alpha
- 9 days ago - Hippocratic AI Establishes a Healthcare Advisory Board Comprised of Seven Industry Visionaries and Business Leaders - Business Wire
- 14 days ago - Clover Health Investments, Corp. (CLOV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Clover Health's Rally: The Payoff Of A Profitable Pivot - Seeking Alpha
- 4 weeks ago - Clover Health to Report Third Quarter 2024 Financial Results on November 6 - GlobeNewsWire
- 5 weeks ago - 2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors - GlobeNewsWire
- 5 weeks ago - Clover Health PPO Medicare Advantage Plans Earn 4 Star Rating for 2025 - GlobeNewsWire
- 6 weeks ago - Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer - GlobeNewsWire